FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/077797 [Registered on: 06/12/2024] Trial Registered Prospectively
Last Modified On: 01/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Comparison between nerve block located behind nose and oral medical management for headache that occur after spinal anaesthesia in cesarean section 
Scientific Title of Study   Comparison between Sphenopalatine ganglion block versus conservative management for postdural puncture headache in cesarean section 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Prema I Tondi 
Designation  Postgraduate 
Affiliation  Kodagu Institute of Medical sciences 
Address  Department of Anesthesiology, Kodagu Institute of Medical sciences teaching hospital , madikeri

Kodagu
KARNATAKA
571201
India 
Phone  9945275198  
Fax    
Email  Prematondi@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Taranandan A 
Designation  Associate professor 
Affiliation  Kodagu Institute of Medical sciences 
Address  department of anaesthesiology Kodagu Institute of Medical sciences teaching hospital , madikeri

Kodagu
KARNATAKA
571201
India 
Phone  9481267056  
Fax    
Email  drtararoshan@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Taranandan A 
Designation  ASSOCIATE PROFESSOR 
Affiliation  Kodagu Institute of Medical sciences 
Address  Department of anaesthesiology Kodagu Institute of Medical sciences teaching hospital , madikeri

Kodagu
KARNATAKA
571201
India 
Phone  9481267056  
Fax    
Email  drtararoshan@gmail.com  
 
Source of Monetary or Material Support  
Kodagu Institute of Medical Sciences Madikeri,Kodagu district madikeri 571201 karnatak india 
 
Primary Sponsor  
Name  Kodagu institute of medical sciences 
Address  Kodagu Institute of Medical sciences teaching hospital 571201 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Dr TARANANDAN A  Kodagu Institute of Medical Sciences, teaching hospital Madikeri 571201 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Prema  Kodagu institute of medical sciences , teaching hospital   Postop ward in maternal and child health block. Kodagu institute of medical sciences,Madikeri ,571201,
Kodagu
KARNATAKA 
9945275198

Prematondi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Kodagu Institute of Medical Sciences  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O998||Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  conservative treatment  Tablet paracetmol 500mg thrice a day  
Intervention  Sphenopalatine ganglion block   Cotton swab soaked in 4% lignocaine with adernaline ,inserted through nostril directed parallel to floor of nose until resistance encountered 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1. Obstetric patient with diagnosed PDPH who underwent Lower segment caesarean section under subarachnoid block.
2. Age more than 18years 
 
ExclusionCriteria 
Details  1. History of allergy to local anesthetic
2. Had opioid taken less than 12hrs before the study inclusion.
3. Preeclampsia, Eclampsia, chronic hypertension
4. Known coagulopathy.
5. Nasal septal deviation
6. Nasal polyp
7. History of nasal bleeding
8. Nasal and basal bone fracture 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
efficacy of sphenopalatine ganglion block and conservative measures in PDPH and objective is to compare the efficacy of sphenopalatine ganglion block and conservative treatment with respect to reduction in pain score.  15 min, 60 min, 6-hour,12 hour and 24 hours. 
 
Secondary Outcome  
Outcome  TimePoints 
1.Onset of analgesia
2.Hemodynamic effects BP, PR, SpO2
3.Proportion of patient requiring rescue analgesia
4.Requirement of epidural blood patch 
15 min, 60 min, 6-hour,12 hour and 24 hours. 
 
Target Sample Size   Total Sample Size="240"
Sample Size from India="240" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   12/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  12/12/2024 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The aim is comparing the efficacy of sphenopalatine ganglion block and conservative measures in PDPH and objective is to compare the efficacy of51 sphenopalatine ganglion block andconservative treatment with respect to reduction in pain score at 15 min, 60 min, 6-hour,12 hour and 24 hours in PDPH. In both the groups sphenopalatine ganglion block and conservative management will be given by my colleague in ward for patient of PDPH, after 5 min I am going to assess pain score.

Patient will be assessed using NRS Numeric Pain Rating Scale 0-10

0-3 = no pain 

3-7 = moderate pain 

8-10 = worst possible 

Pain score will be assessed at 15 min, 60 min, 6-hour,12 hour and 24 hours in both groups after an intervention and time at which NRS score declines will be considered as onset of analgesia in both the groups. At 15 min, 60 min, 6-hour, 12 hour and 24-hour vital parameters like BP, PR, SPO2 will be recorded. Along with pain, patients will be asked about the sensation of nausea and vomiting. After 6 hours if NRS score is >7 it means pain is not relieved, patient will be marked as a failure, then rescue therapy will be considered. Patients in both groups without pain relief after 24 h will be considered for Epidural blood patch.

Any adverse events that occur in study will be treated according to standard protocol.

 
Close